Neuberger Berman Group LLC Ultragenyx Pharmaceutical Inc. Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 5,614 shares of RARE stock, worth $251,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,614
Holding current value
$251,226
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$40.21 - $59.36 $3.99 Million - $5.9 Million
-99,325 Reduced 94.65%
5,614 $311,000
Q1 2024

Nov 14, 2024
BUY
$43.02 - $53.69 $1.51 Million - $1.89 Million
35,193 Added 50.46%
104,939 $4.9 Million
Q1 2024

May 13, 2024
BUY
$43.02 - $53.69 $4.51 Million - $5.63 Million
104,939 New
104,939 $4.9 Million
Q4 2023

Nov 14, 2024
BUY
$31.73 - $49.19 $2.21 Million - $3.43 Million
69,746 New
69,746 $3.34 Million
Q4 2023

Feb 09, 2024
SELL
$31.73 - $49.19 $2.01 Million - $3.11 Million
-63,240 Reduced 47.55%
69,746 $3.34 Million
Q3 2023

Nov 14, 2023
BUY
$34.92 - $46.66 $1.06 Million - $1.42 Million
30,341 Added 29.56%
132,986 $4.74 Million
Q2 2023

Aug 11, 2023
BUY
$37.35 - $52.15 $1.27 Million - $1.77 Million
33,969 Added 49.46%
102,645 $4.74 Million
Q1 2023

May 12, 2023
BUY
$36.99 - $48.71 $1.07 Million - $1.41 Million
28,890 Added 72.61%
68,676 $2.75 Million
Q4 2022

Feb 13, 2023
BUY
$33.72 - $46.33 $1.34 Million - $1.84 Million
39,786 New
39,786 $1.84 Million
Q2 2021

Aug 13, 2021
SELL
$92.19 - $115.71 $1.71 Million - $2.15 Million
-18,585 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$106.9 - $167.73 $645,889 - $1.01 Million
-6,042 Reduced 24.53%
18,585 $2.12 Million
Q4 2020

Feb 10, 2021
SELL
$84.4 - $177.39 $200,281 - $420,946
-2,373 Reduced 8.79%
24,627 $3.41 Million
Q3 2020

Nov 12, 2020
BUY
$72.98 - $90.0 $510,860 - $630,000
7,000 Added 35.0%
27,000 $2.22 Million
Q2 2020

Aug 13, 2020
SELL
$46.91 - $78.22 $93,820 - $156,440
-2,000 Reduced 9.09%
20,000 $1.56 Million
Q1 2020

May 14, 2020
BUY
$33.8 - $62.9 $743,599 - $1.38 Million
22,000 New
22,000 $977,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.13B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email